Immuneering (IMRX)
(Delayed Data from NSDQ)
$1.87 USD
+0.01 (0.54%)
Updated Nov 1, 2024 03:59 PM ET
After-Market: $1.86 -0.01 (-0.53%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth B Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/14/24 |
---|---|
Current Quarter | -0.54 |
EPS Last Quarter | -0.47 |
Last EPS Surprise | 7.84% |
ABR | 1.88 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -1.89 |
Next Year | -1.60 |
EPS (TTM) | -1.91 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | 0.32M | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.54 | -0.48 | -1.89 | -1.60 |
# of Estimates | 4 | 4 | 5 | 5 |
Most Recent Consensus | NA | NA | -1.61 | -0.75 |
High Estimate | -0.49 | -0.30 | -1.61 | -0.75 |
Low Estimate | -0.58 | -0.65 | -2.18 | -2.38 |
Year ago EPS | -0.43 | -0.52 | -1.88 | -1.89 |
Year over Year Growth Est. | -25.58% | 7.69% | -0.53% | 15.34% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 1 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.54 | -0.48 | -1.89 | -1.60 |
7 Days Ago | -0.54 | -0.48 | -1.89 | -1.60 |
30 Days Ago | -0.54 | -0.48 | -1.89 | -1.60 |
60 Days Ago | -0.54 | -0.48 | -1.90 | -1.60 |
90 Days Ago | -0.53 | -0.51 | -1.93 | -2.01 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.54 | -0.48 | -1.89 | -1.60 |
Zacks Consensus Estimate | -0.54 | -0.48 | -1.89 | -1.60 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.47 | -0.49 | -0.52 | -0.43 | NA |
Estimate | -0.51 | -0.45 | -0.48 | -0.51 | NA |
Difference | 0.04 | -0.04 | -0.04 | 0.08 | 0.01 |
Surprise | 7.84% | -8.89% | -8.33% | 15.69% | 1.58% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more